<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Nanostring-Technologies on Bioecon</title><link>https://en.bioecon.ru/companies/nanostring-technologies/</link><description>Recent content in Nanostring-Technologies on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Wed, 22 Jul 2026 21:36:41 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/nanostring-technologies/index.xml" rel="self" type="application/rss+xml"/><item><title>Spatial transcriptomics &amp; spatial multi-omics</title><link>https://en.bioecon.ru/technology/spatial-transcriptomics-spatial-multi-omics/</link><pubDate>Wed, 22 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/spatial-transcriptomics-spatial-multi-omics/</guid><description>Mapping gene expression — and increasingly proteins — directly onto intact tissue sections, so each transcript keeps its x/y address and the tumour microenvironment becomes a navigable map rather than a bulk average.</description></item><item><title>Spatial epigenomics</title><link>https://en.bioecon.ru/technology/spatial-epigenomics/</link><pubDate>Mon, 06 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/spatial-epigenomics/</guid><description>Mapping chromatin accessibility, DNA methylation and histone marks directly on a tissue section instead of a dissociated cell suspension, using in situ Tn5 transposition and microfluidic barcoding to build 3D atlases of a tumor&amp;rsquo;s epigenetic state at 10-micron resolution — the layer of hardware and reagents beneath precision oncology&amp;rsquo;s biggest 2026 push.</description></item></channel></rss>